Clinical trial
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00287963 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00287963 |
|---|---|
| Title | Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer |
| Official title | A Phase I Study of Topotecan in Combination With Vinorelbine in Recurrent Lung Cancer |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride, vinorelbine tartrate |
| Enrollment | 18 |
| Start date | Feb 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Feb 7, 2006 |
| Last update posted | May 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: